Skip to main content
Have a personal or library account? Click to login
Recombinant human erythropoietin alters gene expression and stimulates proliferation of MCF-7 breast cancer cells Cover

Recombinant human erythropoietin alters gene expression and stimulates proliferation of MCF-7 breast cancer cells

Radiology and Oncology
Volume 47 (2013): Issue 4 (December 2013)
By: ,  ,  ,  ,  ,   and    
Open Access
|Oct 2013
References

References

  1. 1. Moritz KM, Lim GB, Wintour EM. Developmental regulation of erythropoietin and erythropoiesis.1997;R1829-44.
    Open DOISearch in Google Scholar
  2. 2. Jelkmann W, Bohlius J, Hallek M, Sytkowski AJ. The erythropoietin receptor in normal and cancer tissues.2008;39-61.
    Open DOISearch in Google Scholar
  3. 3. Koury MJ, Bondurant MC. The molecular mechanism of erythropoietin action.1992;649-63.
    Open DOISearch in Google Scholar
  4. 4. Dessypris EN, Krantz SB. Effect of pure erythropoietin on DNA-synthesis by human marrow day 15 erythroid burst forming units in short-term liquid culture.1984;295-306.
    Open DOISearch in Google Scholar
  5. 5. Silva M, Grillot D, Benito A, Richard C, Nunez G, Fernandez-Luna JL. Erythropoietin can promote erythroid progenitor survival by repressing apoptosis through Bcl-XL and Bcl-2.1996;1576-82.
    Open DOISearch in Google Scholar
  6. 6. Elliott S, Sinclair AM. The effect of erythropoietin on normal and neoplastic cells.2012;163-89.
    Search in Google Scholar
  7. 7. Westenfelder C, Baranowski RL. Erythropoietin stimulates proliferation of human renal carcinoma cells.2000;647-57.
    Open DOISearch in Google Scholar
  8. 8. Kumar SM, Acs G, Fang D, Herlyn M, Elder DE, Xu XW. Functional erythropoietin autocrine loop in melanoma.2005;823-30.
    Open DOISearch in Google Scholar
  9. 9. Selzer E, Wacheck V, Kodym R, Schlagbauer-Wadl H, Schlegel W, Pehamberger H, et al. Erythropoietin receptor expression in human melanoma cells.2000;421-6.
    Open DOISearch in Google Scholar
  10. 10. Ludwig H. rHuEPO and treatment outcomes: the preclinical experience.2004;48-54.
    Open DOISearch in Google Scholar
  11. 11. Nakamura Y, Komatsu N, Nakauchi H. A truncated erythropoietin receptor that fails to prevent programmed cell death of erythroid cells.1992;1138-41.
    Open DOISearch in Google Scholar
  12. 12. Todokoro K, Kuramochi S, Nagasawa T, Abe T, Ikawa Y. Isolation of a cDNA encoding a potential soluble receptor for human erythropoietin.1991;283-4.
    Open DOISearch in Google Scholar
  13. 13. Sakanaka M, Wen TC, Matsuda S, Masuda S, Morishita E, Nagao M, et al. In vivo evidence that erythropoietin protects neurons from ischemic damage.1998;4635-40.
    Open DOISearch in Google Scholar
  14. 14. Sinclair AM, Todd MD, Forsythe K, Knox SJ, Elliott S, Begley CG. Expression and function of erythropoietin receptors in tumors: implications for the use of erythropoiesis-stimulating agents in cancer patients.2007;477-88.
    Open DOISearch in Google Scholar
  15. 15. Arcasoy MO, Amin K, Karayal AF, Chou SC, Raleigh JA, Varia MA, et al. Functional significance of erythropoietin receptor expression in breast cancer.2002;911-8.
    Open DOISearch in Google Scholar
  16. 16. Hevir N, Trost N, Debeljak N, Rizner TL. Expression of estrogen and progesterone receptors and estrogen metabolizing enzymes in different breast cancer cell lines.2011;206-16.
    Open DOISearch in Google Scholar
  17. 17. Mounier CM, Wendum D, Greenspan E, Flejou JF, Rosenberg DW, Lambeau G. Distinct expression pattern of the full set of secreted phospholipases A2 in human colorectal adenocarcinomas: sPLA2-III as a biomarker candidate.2008;587-95.
    Open DOISearch in Google Scholar
  18. 18. Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A, et al. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes.2002;RESEARCH0034.
    Open DOISearch in Google Scholar
  19. 19. Bustin SA, Benes V, Garson JA, Hellemans J, Huggett J, Kubista M, et al. The MIQE guidelines: minimum information for publication of quantitative realtime PCR experiments.2009;611-22.
    Open DOISearch in Google Scholar
  20. 20. Smyth GK. Limma: linear models for microarray data. In: Robert Gentleman VJC, Wolfgang Huber, Rafael A. Irizarry, Sandrine Dudoit editor.. New York: Springer; 2005. p.397-420.
    Open DOISearch in Google Scholar
  21. 21. (2008) RDCT.. Vienna: R Fundation for Statistical Computing; 2011.
    Search in Google Scholar
  22. 22. Benjamini Y. Hochberg Y. Controlling the false discovery rate - a practical and powerful approach to multiple testing.1995;289-300.
    Open DOISearch in Google Scholar
  23. 23. Noguchi CT, Asavaritikrai P, Teng R, Jia Y. Role of erythropoietin in the brain.2007;159-71.
    Open DOISearch in Google Scholar
  24. 24. Nishiya D, Omura T, Shimada K, Matsumoto R, Kusuyama T, Enomoto S, et al. Effects of erythropoietin on cardiac remodeling after myocardial infarction.2006;31-9.
    Open DOISearch in Google Scholar
  25. 25. Szenajch J, Wcislo G, Jeong JY, Szczylik C, Feldman L. The role of erythropoietin and its receptor in growth, survival and therapeutic response of human tumor cells From clinic to bench - a critical review.2010;82-95.
    Search in Google Scholar
  26. 26. Liang K, Esteva FJ, Albarracin C, Stemke-Hale K, Lu Y, Bianchini G, et al. Recombinant human erythropoietin antagonizes trastuzumab treatment of breast cancer cells via Jak2-mediated Src activation and PTEN inactivation.2010;423-35.
    Open DOISearch in Google Scholar
  27. 27. Trost N, Hevir N, Rizner TL, Debeljak N. Correlation between erythropoietin receptor(s) and estrogen and progesterone receptor expression in different breast cancer cell lines.2013;717-25.
    Open DOISearch in Google Scholar
  28. 28. Lu C, Shen Q, DuPre E, Kim H, Hilsenbeck S, Brown PH. cFos is critical for MCF-7 breast cancer cell growth.2005;6516-24.
    Open DOISearch in Google Scholar
  29. 29. Liu WM, Powles T, Shamash J, Propper D, Oliver T, Joel S. Effect of haemopoietic growth factors on cancer cell lines and their role in chemosensitivity.2004;981-90.
    Open DOISearch in Google Scholar
  30. 30. Vivacqua A, Bonofiglio D, Recchia AG, Musti AM, Picard D, Ando S, et al. The G protein-coupled receptor GPR30 mediates the proliferative effects induced by 17beta-estradiol and hydroxytamoxifen in endometrial cancer cells.2006;631-46.
    Open DOISearch in Google Scholar
  31. 31. Trost N, Juvan P, Sersa G, Debeljak N. Contrasting effect of recombinant human erythropoietin on breast cancer cell response to cisplatin induced cytotoxicity.2012;213-25.
    Open DOISearch in Google Scholar
  32. 32. Arcasoy MO, Jiang X, Haroon ZA. Expression of erythropoietin receptor splice variants in human cancer.2003;999-1007.
    Open DOISearch in Google Scholar
  33. 33. Singh S, Dev A, Verma R, Pradeep A, Sathyanarayana P, Green JM, et al. Defining an EPOR- regulated transcriptome for primary progenitors, including Tnfr-sf13c as a novel mediator of EPO- dependent erythroblast formation.2012;e38530.
    Open DOISearch in Google Scholar
DOI: https://doi.org/10.2478/raon-2013-0056 | Journal eISSN: 1581-3207 | Journal ISSN: 1318-2099
Journal RSS Feed
Language: English
Page range: 382 - 389
Published on: Oct 8, 2013
Published by: Association of Radiology and Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
breast cancer,
erythropoietin,
erythropoietin receptor isoforms,
proliferation,
gene expression
Related subjects:
Medicine,
Clinical medicine,
Radiology

© 2013 Nina Trost, Tina Stepisnik, Sabina Berne, Anja Pucer, Toni Petan, Radovan Komel, Natasa Debeljak, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons License.

Volume 47 (2013): Issue 4 (December 2013)
Previous article
Next article